Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | OPRM1 | P35372 | 1/20 | 0.55 |
| ▸ | TSHR | P16473 | 1/20 | 0.53 |
| ▸ | THRB | P10828 | 1/20 | 0.53 |
| ▸ | LMNA | P02545 | 2/20 | 0.53 |
| ▸ | DNM1 | Q05193 | 2/20 | 0.50 |
| ▸ | SPHK1 | Q9NYA1 | 1/20 | 0.50 |
| ▸ | ADH1B | P00325 | 1/20 | 0.46 |
| ▸ | ADH1C | P00326 | 1/20 | 0.46 |
| ▸ | ADH1A | P07327 | 1/20 | 0.46 |
| ▸ | ADH4 | P08319 | 1/20 | 0.46 |
| ▸ | ADH7 | P40394 | 1/20 | 0.46 |
| ▸ | PLA2G1B | P04054 | 1/20 | 0.46 |
| ▸ | PLA2G2A | P14555 | 1/20 | 0.46 |
| ▸ | ACE2 | Q9BYF1 | 1/20 | 0.44 |
| ▸ | FDPS | P14324 | 3/20 | 0.44 |
| ▸ | GPR84 | Q9NQS5 | 2/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3002559 | 1.00 | OPRM1 (0.55) | OPRM1TSHRTHRBLMNADNM1 | |
| SCHEMBL3223191 | 1.00 | OPRM1 (0.55) | OPRM1TSHRTHRBLMNADNM1 | |
| SCHEMBL671913 | 1.00 | OPRM1 (0.55) | OPRM1TSHRTHRBLMNADNM1 | |
| SCHEMBL6122664 | 1.00 | OPRM1 (0.55) | OPRM1TSHRTHRBLMNADNM1 | |
| SCHEMBL15148 | 1.00 | OPRM1 (0.55) | OPRM1TSHRTHRBLMNADNM1 | |
| SCHEMBL157759 | 1.00 | OPRM1 (0.55) | OPRM1TSHRTHRBLMNADNM1 | |
| Hexadecane SCHEMBL23000686 | 1.00 | OPRM1 (0.55) | OPRM1TSHRTHRBLMNADNM1 | |
| Octane SCHEMBL7455770 | 1.00 | OPRM1 (0.55) | OPRM1TSHRTHRBLMNADNM1 | |
| SCHEMBL22950680 | 1.00 | OPRM1 (0.55) | OPRM1TSHRTHRBLMNADNM1 | |
| SCHEMBL598884 | 1.00 | OPRM1 (0.55) | OPRM1TSHRTHRBLMNADNM1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 200 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-1999038485-A1 | COSMETIC COMPOSITIONS | THE PROCTER & GAMBLE COMPANY (US) | 1999-08-05 | — | — | WO | claimed |
| US-5919467-A | BRANCHED CHAIN ALIPHATIC HYDROCARBON, POLYETHYLENE PARTICLES, CROSSLINKED ACRYLATE POLYMER, ALKYLMETHYLSILOXANE | THE PROCTOR & GAMBLE COMPANY (US) | 1999-07-06 | — | — | US | claimed |
| WO-1996015762-A1 | COSMETIC COMPOSITIONS IN STICK FORM | THE PROCTER & GAMBLE COMPANY (US) | 1996-05-30 | — | — | WO | claimed |
| WO-1996015760-A1 | COSMETIC COMPOSITIONS IN STICK FORM | THE PROCTER & GAMBLE COMPANY (US) | 1996-05-30 | — | — | WO | claimed |
| WO-1996015761-A1 | COSMETIC COMPOSITIONS IN STICK FORM | THE PROCTER & GAMBLE COMPANY (US) | 1996-05-30 | — | — | WO | claimed |
| US-20210236403-A1 | COSMETIC, PERSONAL CARE, AND CLEANING PRODUCTS | Planet Lindsay, LLC (US) | 2021-08-05 | — | — | US | disclosed |
| US-10682383-B2 | Personal care compositions with improved hyposensitivity | THE PROCTER & GAMBLE COMPANY (US) | 2020-06-16 | — | — | US | disclosed |
| US-20190111095-A1 | Personal Care Compositions With Improved Hyposensitivity | PROCTER & GAMBLE (US) | 2019-04-18 | — | — | US | disclosed |
| US-10183051-B2 | Personal care compositions with improved hyposensitivity | THE PROCTER & GAMBLE COMPANY (US) | 2019-01-22 | — | — | US | disclosed |
| US-20170128512-A1 | Personal Care Compositions With Improved Hyposensitivity | PROCTER & GAMBLE (US) | 2017-05-11 | — | — | US | disclosed |
| US-9585866-B2 | Personal care compositions with improved hyposensitivity | THE PROCTER & GAMBLE COMPANY (US) | 2017-03-07 | — | — | US | disclosed |
| US-9084734-B2 | Peptide personal care compositions and methods for their use | DANISCO US INC. (US) | 2015-07-21 | — | — | US | disclosed |
| WO-1998050005-A1 | COMPOSITIONS FOR COSMETIC APPLICATIONS | MEDLOGIC GLOBAL CORPORATION (US) | 1998-11-12 | — | — | WO | disclosed |
| EP-0785763-A4 | — | — | 1997-07-30 | — | — | EP | disclosed |
| EP-0785763-A1 | POWDER COSMETIC COMPOSITIONS | THE PROCTER & GAMBLE COMPANY (US) | 1997-07-30 | — | — | EP | disclosed |
| EP-0752845-A4 | POWDER COSMETIC COMPOSITIONS | PROCTER & GAMBLE (US) | 1997-03-19 | — | — | EP | disclosed |
| EP-0752845-A1 | POWDER COSMETIC COMPOSITIONS | THE PROCTER & GAMBLE COMPANY (US) | 1997-01-15 | — | — | EP | disclosed |
| EP-0500423-B1 | Cleansing composition containing synthetic oil and method for carrying it out | OREAL (FR) | 1996-01-24 | — | — | EP | disclosed |
| WO-1995025503-A1 | POWDER COSMETIC COMPOSITIONS | THE PROCTER & GAMBLE COMPANY (US) | 1995-09-28 | — | — | WO | disclosed |
| WO-1995025499-A1 | POWDER COSMETIC COMPOSITIONS | THE PROCTER & GAMBLE COMPANY (US) | 1995-09-28 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10682383-B2 | Personal care compositions with improved hyposensitivity | CUTA, DPM1, PIEZO1 | OPRM1 3922/4885TSHR 3458/4885THRB 986/4885 |
| US-20190111095-A1 | Personal Care Compositions With Improved Hyposensitivity | CUTA, DPM1, PIEZO1 | OPRM1 3922/4885TSHR 3458/4885THRB 986/4885 |
| US-10183051-B2 | Personal care compositions with improved hyposensitivity | CUTA, DPM1, PIEZO1 | OPRM1 3922/4885TSHR 3458/4885THRB 986/4885 |
| US-20170128512-A1 | Personal Care Compositions With Improved Hyposensitivity | CUTA, DPM1, PIEZO1 | OPRM1 3922/4885TSHR 3458/4885THRB 986/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.